compound of semaglutide | C187H291N45O59 | CID 56843331 Semaglutide Compound – Alliant LTC
Description
Across studies, definitions of pregnancy-related endpoints, treatment duration, discontinuation structure, washout timing, concomitant metformin use, and post-treatment conception attempts vary substantially

In CVOTs, liraglutide, semaglutide and dulaglutide demonstrated appreciable cardiovascular and renal protective effects, among which liraglutide had an appreciable effect on mitigating the risk of cardiovascular death [4], while semaglutide and dulaglutide conferred a risk reduction on non-fatal stroke [22, 23]

Nausea is the most frequently reported side effect, typically appearing within 2448 hours of your first injection and peaking around day 35

For instance, a clinical trial of 11,000 people found that using GLP-1 RAs reduced kidney disease progression by 18%, kidney failure by 16% and risk of cardiac events by 13%

The active ingredient is still in clinical development and should not be equated with already approved medications such as Wegovy, Mounjaro, or Saxenda

[DOI] [PMC free article] [PubMed] [Google Scholar] 9.Scientific Advisory Committee on Nutrition Report on the Dietary Reference Values for Energy
